MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-08-0015632
Akognos Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.97 Cr
▲ 5% YoY
Net profit · FY 2025
₹22.43 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹1.74 Cr
EBITDA margin 17.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹2.5 Cr
Satisfied ₹14.5 Lakh
Company age
11 yrs
Est. 2015
Employees · EPFO
27
Provident fund records
About Akognos Life Sciences Private Limited
Data last updated:
Akognos Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2015PTC288792. Its GSTIN is 07AAOCA0460B1Z4 (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Seema Kaul and Prashant Pareek.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No. 1 49 Chruch Road Jangpura Bhogal, Delhi, India – 110014.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.97 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹22.43 Lakh (net margin 2.2%) and EBITDA of ₹1.74 Cr (EBITDA margin 17.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 11% over five years.
The company has about 27 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Akognos Life Sciences. As per MCA filings, the company has open charges of ₹2.5 Cr and satisfied charges of ₹14.5 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in January 2017. Its 5 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is N B Marketing Private Limited with revenue of ₹9.98 Cr.
Akognos Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0015632). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website akognoslifesciences.com.
Company details
CIN U74999DL2015PTC288792
Registration Number 288792
Incorporation Date 22 December 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-08-0015632
Key People
Seema Kaul Director Prashant Pareek Director Recognitions & Rankings of Akognos Life Sciences
Contact details
Akognos Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is akognoslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressRoom No. 1 49 Chruch Road Jangpura Bhogal, Delhi, India – 110014
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Akognos Life Sciences Private Limited, buy the company report.
Comprehensive company report
Akognos Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Akognos Life Sciences operates one associated brand: Akognos Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers academic assistance and innovative ideas to enhance patient care. | akognoslifesciences.com |
Business activity
The main business activity of Akognos Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Akognos Life Sciences Private Limited, buy the company report.
Financials of Akognos Life Sciences Private Limited
FY 2025 filings availableAkognos Life Sciences Private Limited reported revenue of ₹9.97 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹9.97 Cr ▲ 5%
Net profit · FY 2025
₹22.43 Lakh margin 2.2%
EBITDA · FY 2025
₹1.74 Cr margin 17.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 7%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 25%
5 years · compounded
▲ 94%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 5% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹22.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akognos Life Sciences Private Limited, buy the company report.
Board of directors of Akognos Life Sciences Private Limited
Akognos Life Sciences has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Kaul | Director | 02 Aug 2023 | 3 Years 2 Months | Current |
| Prashant Pareek | Director | 10 Aug 2016 | 10 Years 2 Months | Current |
Peer comparison
Akognos Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| N B Marketing Private Limited | ₹9.98 Cr (FY 2025) | Delhi, India | ||||
| Concur Pharmaceuticals Private Limited | ₹9.98 Cr (FY 2024) | 17.0% | Delhi, India | |||
| Akognos Life Sciences Private Limitedthis company | ₹9.97 Cr (FY 2025) | ₹22.43 Lakh | 2.2% | 5.0% | 27 | Delhi, India |
| Gupta Medico Agencies Private Limited | ₹9.95 Cr (FY 2024) | 17.0% | Mandi, Himachal Pradesh, India | |||
| Zaddoc Nutrition Private Limited | ₹9.92 Cr (FY 2019) | Ahmedabad, Gujarat, India | ||||
| Valpra Biotech Private Limited | ₹9.92 Cr (FY 2024) | 5.0% | Karnataka, India |
To see the full peer comparison of Akognos Life Sciences Private Limited, buy the company report.
Auditor
Akognos Life Sciences Private Limited is audited by BAHL CHANDHOKE for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAHL CHANDHOKE | FY 2023 | 002537N |
Shareholding
The shareholding of Akognos Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Akognos Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.5 Cr
Satisfied charges
₹14.5 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Dec 2017 | 100144362 | Indian Bank | ₹2.5 Cr | Open | |
| 26 May 2017 | 100103850 | Others | ₹14.5 Lakh | Satisfied |
To see the full charge records of Akognos Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Akognos Life Sciences Private Limited has 1 deal on record (1 secondary share transfer); the latest was in January 2017.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2017 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Akognos Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State of U.P. | Pending |
| District court, Gautam Buddha Nagar, Uttar Pradesh | Criminal case | Filed against the company by State Government | Pending |
To see the full case history of Akognos Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akognos Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Akognos Life Sciences Private Limited has a workforce of 27 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
42.11%
GST
Akognos Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOCA0460B1Z4 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Akognos Life Sciences Private Limited, buy the company report.
Recent activity
Akognos Life Sciences Private Limited has 9 board changes on record since 2016: 2 appointments and 7 cessations. The latest: Seema Kaul ceased to be Additional Director on 26 Sep 2023.
AGM
Akognos Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Akognos Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Indian Bank of Rs. 2.50 Cr registered on 01 Dec 2017 with Charge ID 100144362 was modified on 21 Feb 2025.
Ceased
Seema Kaul ceased to be Additional Director.
Appointed
Seema Kaul was appointed as Director.
Ceased
Reena Srivastava ceased to be Director.
Ceased
Shuchi Pareek ceased to be Director.
Ceased
Palak Kalia ceased to be Additional Director.
Charges
A charge registered on 26 May 2017 via Charge ID 100103850 with Others was fully satisfied on 01 Jan 2018.
Charges
A charge with Indian Bank amounted to Rs. 2.50 Cr with Charge ID 100144362 was registered on 01 Dec 2017.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100103850 was registered on 26 May 2017.
Ceased
Nitish Dhingra ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Akognos Life Sciences is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 December 2015 (11+ years old) and is registered under CIN U74999DL2015PTC288792.
Akognos Life Sciences has 2 current directors:
- Seema Kaul - Director
- Prashant Pareek - Director
The latest financial statements of Akognos Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Akognos Life Sciences is 07AAOCA0460B1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Akognos Life Sciences is U74999DL2015PTC288792. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akognos Life Sciences has 2 court cases on record: 2 filed against it. 2 are pending.
Akognos Life Sciences was incorporated on 22 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Akognos Life Sciences has 1 deal on record (1 secondary share transfer); the latest was in January 2017.
The peers of Akognos Life Sciences by revenue are N B Marketing Private Limited, Concur Pharmaceuticals Private Limited, Gupta Medico Agencies Private Limited, Zaddoc Nutrition Private Limited, Valpra Biotech Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Seema Kaul ceased to be Additional Director on 26 Sep 2023. Seema Kaul was appointed as Director on 02 Aug 2023. Reena Srivastava ceased to be Director on 01 Apr 2022. Akognos Life Sciences has 9 board changes on record in total.
Yes, Akognos Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-DL-08-0015632).